Argentina 
Austria 
Brazil 
France 
Germany 
Hong Kong 
Malaysia 
Mexico 
Netherlands 
Poland 
Singapore 
Switzerland 
Thailand 
United Arab Emirates 
United Kingdom (UK) 
Advancing Sialoglycan Research:
TRB at the Hannover Conference (past event)
TRB had the pleasure of attending the “Sialoglycans in Development and Immunity” Conference, held in Hannover, Germany from October 9 to 11. It was an excellent event organized by Dr Martina Mühlenhoff, biochemist at the Institute of Clinical Biochemistry, and the Research Unit FOR2953 “Sialic Acid as a Regulator in Development and Immunity” of the Hannover Medical School.
One hundred sialoglycan researchers from over 10 countries convened to exchange and share their expertise. Their discussions focused on the role of sialoglycans in several key areas, including but not limited to: the functioning of the immune system, the proper formation of neuronal networks, and the maturation of the kidneys.
TRB was honored to take part in this first-time meeting in the world of sialoglycan fundamental research. It allowed its representative to be in contact with specialized researchers with diverse backgrounds and visions. We were especially proud to see the results of dedicated work of our scientific collaborations: Prof. Simonetta Sipione from the University of Alberta, Canada, and Dr. Markus Abeln, from the Hannover Medical School.
Simonetta Sipione is a renowned Professor with a special interest in researching the roles of gangliosides in neurodegeneration, neuroinflammation, and neuroprotection. With a strong biochemistry background, she seeks to decipher the molecular mechanisms of GM1 and other gangliosides in Huntington’s Disease. During the conference, she presented her latest discoveries in the understanding these mechanisms. For more details, visit her laboratory’s site, Sipione Laboratory.
Markus Abeln, a dynamic TRB partner in fundamental/scientific research, presented his recent findings on the role of monosialoganglioside (GM1) in protecting the mice embryo against the attack of the mother’s immune system. The newly revealed roles of GM1 in immunity mark a further step in comprehending this complex and potent molecule. See the related Nature article for more information.
Beyond established partnerships, the conference enabled us to explore new collaborative opportunities and delve deeper into the broader functions of sialoglycans. A highlight was the innovative work of Martina Mühlenhoff, who developed a technique uncovering the O-acetylation of sialic acids, significantly impacting their viral interactions. Read more about her pioneering research in this Nature Communications article.
TRB extends heartfelt gratitude to the organizers for welcoming us into this vibrant, expert community. Immersed in the evolving world of sialoglycans and gangliosides, we gained a deeper appreciation of GM1 and its pivotal role in the sialoglycans’ family. We eagerly anticipate next year’s conference, where we hope to uncover more breakthroughs in this field.
Find out more about the fascinating world of GM1 and its implications in health and science.
Celebrate Pharma Innovation at CPHI Barcelona 2023 (past event)
Join TRB at CPHI Barcelona 2023 from October 24 to 26
TRB Chemedica is set to attend the upcoming CPhI Worldwide Congress, a premier international event for the pharmaceutical industry, to showcase our range of high-quality pharmaceutical products and strong distribution network.
As a long-term manufacturer of Hyaluronic Acid, Diacerein and GM1 Ganglioside products, we strive to provide patients across the globe the opportunity to access our products. Our enduring and robust partnerships with well-established agents ensure our presence in over 70 countries. However, we are always looking to expand our network even further. We invite you to check out our interactive map to see if we are distributed in your country.
Moreover, our expertise in manufacturing, promoting, distributing and selling pharmaceutical products in the therapeutic areas of rheumatology, ophthalmology and neurology pushes us to always look for additional innovative solutions for patients.
The CPHI Worldwide Congress will offer an excellent opportunity for prospective collaborators and distributors to engage with us, learn about our products, and discuss potential partnerships so please feel free to visit us at booth 2T69.
Join us at ESCRS 2023 Booth C476. We look forward to seeing you in Vienna! (past event)
The European Society of Cataract and Refractive Surgeons (ESCRS) is pleased to invite you to the 41st ESCRS Congress, taking place from September 8-12, 2023, at the Messe Wien Exhibition & Congress Centre in Vienna, Austria. This year’s congress will focus on the future of cataract and refractive surgery, with a comprehensive program of scientific sessions, workshops, and hands-on courses.
Join us at Join Us at Booth C476. We look forward to seeing you in Vienna!
Join us at the Isokinetic Football Medicine Conference 2023 in London! (past event)
At TRB we know the importance of taking care of our athletes’ tendons. Tendinopathy, a common injury among football players, can lead to chronic pain and even career-ending consequences. That’s why we’re excited to announce our presence at the Isokinetic Football Medicine Conference 2023 in London.
At the conference, we’ll join other experts in the field to discuss the latest advancements in football medicine and share our product’s benefits in caring for tendons and tendinopathies. Our product has been specifically designed to help alleviate the pain and discomfort experienced by players suffering from tendinopathy, while also promoting tendon healing and improving tendon function.
We encourage all sports medicine professionals to join us at the conference and contribute to the discussion on how we can improve player health worldwide. By working together, we can ensure that players receive the best possible care and support for their tendons, allowing them to perform at their best on the field. Don’t miss out on this opportunity to network with other like-minded professionals and stay up-to-date on the latest advancements in football medicine. See you there!
Meet us at WCO-IOF-ESCEO Barcelona 2023 on May 4-7 (past event)
We are delighted to announce that we will be participating in the WCO-IOF-ESCEO Barcelona 2023, the world’s leading congress on osteoporosis, osteoarthritis and musculoskeletal diseases. This congress, organized by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), will take place from May 4 to May 7, 2023 in Barcelona, Spain.
This is a great opportunity for us to showcase our innovative products for osteoarthritis and other musculoskeletal conditions. We will be presenting our latest research, clinical data and solutions at our booth n°28. We invite you to come and visit us and learn more about how we can help you improve your patients’ quality of life.
We look forward to meeting you at WCO-IOF-ESCEO Barcelona 2023 and sharing our passion for musculoskeletal health.
Learn more about our products for osteoarthritis and other musculoskeletal conditions on our swiss website.
Join TRB at CPHI North America from April 25 to 27 (past event)
We are excited to announce that TRB will be participating in the CPHI North America 2023, the premier event for the US pharma industry. Come and visit us on booth 643 from April 25-27 in Philadelphia, where you can learn more about our cutting-edge APIs, our company and our services. This is a great opportunity to find out how we can support you in reaching your objectives. We look forward to seeing you there!
Learn more about CPHI.
Find out more about TRB
We are proudly sponsoring the 2023 OARSI Conference in Denver to advance osteoarthritis treatment and prevention (past event)
At TRB Chemedica, we are committed to advancing the field of osteoarthritis treatment by researching, developing, manufacturing, and marketing various molecules, such as hyaluronic acid and diacerein, to manage osteoarthritis-induced pain.
As osteoarthritis is one of our areas of focus, we are pleased to announce our sponsorship of this year’s Osteoarthritis Research Society International (OARSI) conference in Denver, which is dedicated to advancing prevention and treatment of osteoarthritis, and thus support their mission.
TRB Thailand is celebrating another significant milestone this year
– its 30th anniversary! (past event)
TRB Thailand has a long and significant history dating back to 1997, when the company first started with only three employees. Today, TRB Thailand employs over 120 people, making it a key subsidiary of the TRB Group.
To celebrate this momentous occasion, our amazing Thai team put together a fantastic party that was attended by over one hundred staff members. Speeches were given by several TRB leaders during the evening, making it a truly special event for all who attended.
We are pleased to participate in World Arthritis Day (past event)
World Arthritis Day, referred to as WAD, aims at increasing disease awareness and knowledge on rheumatological conditions around the world. Current estimates list more than 200 rheumatic and musculoskeletal diseases (RMD), but their burden is largely underestimated by the general population. Consequently, a large proportion of patients are either not diagnosed or wait for extended periods of time before consulting their healthcare professionals.
More than 100.000.000 people worldwide suffer from rheumatological symptoms. These symptoms directly impact the quality of life of the patients and their professional activity. The inability to work reduces individuals’ self-esteem and increases their dependence on social assistance, family and friends.
Medical education has for a long time considered RMDs as second priority conditions, which means that symptoms might go unnoticed, misdiagnosed, or mistreated if people don’t have access to rheumatologists, nurses, physical therapists, or other healthcare professionals specifically trained in the field of RMD. As a result, people living with a rheumatic or musculoskeletal disease often have to face their condition alone and are lacking information on their symptoms, diagnosis and treatment options.
World Arthritis Day is intended to raise awareness on the existence and impact of RMD worldwide. This Day is an opportunity for all communities around the world to come together and speak with one voice to bring the much-needed messages to all audiences.
Over the past 20 years, TRB Chemedica has focused its rheumatological activities on osteoarthritis, the most prevalent joint disorder especially in middle-aged and elderly people.
We are pleased to announce our presence at CPHI CONGRESS 2022 (past event)
Every year, CPHI brings together over 100,000 pharmaceutical industry professionals from around the world in physical and online workshops for the purpose of networking and identifying business opportunities. This year’s event is expected to be one of the busiest yet with over 39,000 expected participants.
If you are planning to attend, do not miss the opportunity to visit our stand #41F52.
Please contact our team for more information or to schedule a meeting onsite.